Arcadia Biosciences, Inc. — Director's Dealing 2022

Apr 13, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2022-04-11

Reporting Person: PITLIK LAURA (Chief Marketing Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-11	Stock Option (right to buy)	$1.27	A	31000	Acquired	2032-04-11	Common Stock (31000)	Direct
2022-04-11	Stock Option (right to buy)	$1.27	A	23000	Acquired	2032-04-11	Common Stock (23000)	Direct

Footnotes

F1: 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.

F2: The Option vests in two equal installments occurring on the first, and second anniversary of the date of grant, subject to the Participant's continued service.